Your browser doesn't support javascript.
loading
Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial.
Hodi, F Stephen; Chesney, Jason; Pavlick, Anna C; Robert, Caroline; Grossmann, Kenneth F; McDermott, David F; Linette, Gerald P; Meyer, Nicolas; Giguere, Jeffrey K; Agarwala, Sanjiv S; Shaheen, Montaser; Ernstoff, Marc S; Minor, David R; Salama, April K; Taylor, Matthew H; Ott, Patrick A; Horak, Christine; Gagnier, Paul; Jiang, Joel; Wolchok, Jedd D; Postow, Michael A.
Affiliation
  • Hodi FS; Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: stephen_hodi@dfci.harvard.edu.
  • Chesney J; University of Louisville, Louisville, KY, USA.
  • Pavlick AC; New York University, New York, NY, USA.
  • Robert C; Gustave Roussy, INSERM U981, Paris, France.
  • Grossmann KF; Huntsman Cancer Institute, Salt Lake City, UT, USA.
  • McDermott DF; Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Linette GP; Washington University School of Medicine, St Louis, MO, USA.
  • Meyer N; Institut Universitaire du Cancer, Toulouse, France.
  • Giguere JK; Greenville Health System Cancer Institute, Greenville, SC, USA.
  • Agarwala SS; St Luke's Cancer Center and Temple University, Bethlehem, PA, USA.
  • Shaheen M; University of New Mexico, Albuquerque, NM, USA.
  • Ernstoff MS; Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
  • Minor DR; California Pacific Center for Melanoma Research, San Francisco, CA, USA.
  • Salama AK; Duke University Medical Center, Durham, NC, USA.
  • Taylor MH; Oregon Health & Science University, Portland, OR, USA.
  • Ott PA; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Horak C; Bristol-Myers Squibb, Princeton, NJ, USA.
  • Gagnier P; Bristol-Myers Squibb, Princeton, NJ, USA.
  • Jiang J; Bristol-Myers Squibb, Princeton, NJ, USA.
  • Wolchok JD; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.
  • Postow MA; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.
Lancet Oncol ; 17(11): 1558-1568, 2016 Nov.
Article in En | MEDLINE | ID: mdl-27622997
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Melanoma / Antibodies, Monoclonal Type of study: Clinical_trials Limits: Humans Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2016 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Melanoma / Antibodies, Monoclonal Type of study: Clinical_trials Limits: Humans Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2016 Document type: Article Country of publication: United kingdom